LeMaitre Vascular, Inc. (LMAT)
80.67
+0.18
(+0.22%)
USD |
NASDAQ |
Sep 04, 16:00
80.71
+0.04
(+0.05%)
After-Hours: 20:00
LeMaitre Vascular Debt to Equity Ratio : 0.4526 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4526 |
| March 31, 2026 | 0.4668 |
| December 31, 2025 | 0.4716 |
| September 30, 2025 | 0.4899 |
| June 30, 2025 | 0.5125 |
| March 31, 2025 | 0.5333 |
| December 31, 2024 | 0.5505 |
| September 30, 2024 | 0.0554 |
| June 30, 2024 | 0.0576 |
| March 31, 2024 | 0.0612 |
| December 31, 2023 | 0.0641 |
| September 30, 2023 | 0.0585 |
| June 30, 2023 | 0.0592 |
| March 31, 2023 | 0.0602 |
| December 31, 2022 | 0.0619 |
| September 30, 2022 | 0.064 |
| June 30, 2022 | 0.0667 |
| March 31, 2022 | 0.0604 |
| December 31, 2021 | 0.0627 |
| September 30, 2021 | 0.0662 |
| June 30, 2021 | 0.2124 |
| March 31, 2021 | 0.2672 |
| December 31, 2020 | 0.3174 |
| September 30, 2020 | 0.4751 |
| June 30, 2020 | 0.5327 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1036 |
| December 31, 2019 | 0.1061 |
| September 30, 2019 | 0.0451 |
| June 30, 2019 | 0.0498 |
| March 31, 2019 | 0.0504 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp. | 0.5064 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 640.55M |
| Total Liabilities (Quarterly) | 220.21M |
| Shareholders Equity (Quarterly) | 420.34M |
| Current Ratio | 15.89 |
| Net Debt Paydown Yield | -0.04% |